Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29703009
Publication Date : //

Acute respiratory failure requiring mechanical ventilation in severe chronic obstructive pulmonary disease (COPD).


There are limited data on the epidemiology of acute respiratory failure necessitating mechanical ventilation in patients with severe chronic obstructive pulmonary disease (COPD). The prognosis of acute respiratory failure requiring invasive mechanical ventilation is believed to be grim in this population. The purpose of this study was to illustrate the epidemiologic characteristics and outcomes of patients with underlying severe COPD requiring mechanical ventilation.A retrospective study of patients admitted to a quaternary referral medical intensive care unit (ICU) between January 2008 and December 2012 with a diagnosis of severe COPD and requiring invasive mechanical ventilation for acute respiratory failure.We evaluated 670 patients with an established diagnosis of severe COPD requiring mechanical ventilation for acute respiratory failure of whom 47% were male with a mean age of 63.7 ± 12.4 years and Acute physiology and chronic health evaluation (APACHE) III score of 76.3 ± 27.2. Only seventy-nine (12%) were admitted with a COPD exacerbation, 27(4%) had acute respiratory distress syndrome (ARDS), 78 (12%) had pneumonia, 78 (12%) had sepsis, and 312 (47%) had other causes of respiratory failure, including pulmonary embolism, pneumothorax, etc. Eighteen percent of the patients received a trial of noninvasive positive pressure ventilation. The median duration of mechanical ventilation was 3 days (interquartile range IQR 2-7); the median duration for ICU length of stay (LOS) was 5 (IQR 2-9) days and the median duration of hospital LOS was 12 (IQR 7-22) days. The overall ICU mortality was 25%. Patients with COPD exacerbation had a shorter median duration of mechanical ventilation (2 vs 4 days; P = .04), ICU (3 vs 5 days; P = .01), and hospital stay (10 vs 13 days; P = .01). The ICU mortality (9% vs 27%; P < .001), and the hospital mortality (17% vs 32%; P = .004) for mechanically ventilated patients with an acute exacerbation of severe COPD were lower than those with other etiologies of acute respiratory failure. A 1-unit increase in the APACHE III score was associated with a 1% decrease and having an active cancer was associated with a 45% decrease in ICU survival (P < .001). A discharge home at the time of index admission was associated an increased overall survival compared with any other discharge location (P < .001).We report good early outcomes, but significant long-term morbidity in patients with severe COPD requiring invasive mechanical ventilation for acute respiratory failure. A higher APACHE score and presence of active malignancy are associated with a decrease in ICU survival, whereas a discharge home is associated with an increase in the overall survival.

Authors : Gadre Shruti K , Duggal Abhijit , Mireles-Cabodevila Eduardo , Krishnan Sudhir , Wang Xiao-Feng , Zell Katrina , Guzman Jorge ,

Related products :

Catalog number Product name Quantity
MA-20019 Mouse Monoclonal Anti-Human severe acute respiratory syndrome (SARS)-M 100 ul
MA-20018 Mouse Monoclonal Anti-Human severe acute respiratory syndrome (SARS-E2) 100 ul
65-101 anti_SARS antibody(clone 3A2) A novel type of coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Spike glycoprotein is essential for the infection and 50 ug
65-102 anti_SARS antibody(clone 3A2) A novel type of coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Spike glycoprotein is essential for the infection and 250 ug
MA-20018 Mouse Monoclonal Anti-Human severe acute respiratory syndrome (SARS-E2) Species Reactivity: human coronavirus 100 ul Product tipe: Antibodies
MA-20019 Mouse Monoclonal Anti-Human severe acute respiratory syndrome (SARS)-M Species Reactivity: human coronavirus 100 ul Product tipe: Antibodies
EIAAB27478 Chronic renal failure gene protein,Crfg,Gtpbp4,Nog1,Nucleolar GTP-binding protein 1,Rat,Rattus norvegicus
305-13451 Anti 3_DG_imidazolone Monoclonal Antibody It has been shown that Advanced Glycation End products (AGEs) have been involved in chronic disease with aging, such as diabetes or brain disease. So far, sev 50 UG
B980 Chocolate Agar Base USE For isolation of Neisseria gonorrhoeae from chronic and acute cases of gonococcal infections. Qty per Litre of Medium: 45
B980 Chocolate Agar Base USE : For isolation of Neisseria gonorrhoeae from chronic and acute cases of gonococcal infections. 5x500gm
EIAAB27477 Chronic renal failure gene protein,Crfg,GTP-binding protein NGB,Gtpbp4,Mouse,Mus musculus,Nog1,Nucleolar GTP-binding protein 1
EIAAB27476 Chronic renal failure gene protein,CRFG,GTP-binding protein NGB,GTPBP4,Homo sapiens,Human,NOG1,Nucleolar GTP-binding protein 1
303-08741 tic and noncataractous), renal proximal tubules in patients with diabetic nephropathy and chronic renal failure, diabetic retina, peripheral nerves of diabetic neuropathy, atherosclerotic lesions of a 20UG
orb60602 Disulfiram Disulfiram(Antabuse) is a drug used to support the treatment of chronic alcoholism by producing an acute sensitivity to alcohol. For research use only. 100 mg
31-076 DOK2 is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from chronic myelogenous leukemia (CML) patients in the chronic phase. It may be a critical substrate for p210 (bcr 0.05 mg
31-062 DOK1 is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from chronic myelogenous leukemia (CML) patients in the chronic phase. It may be a critical substrate for p210 (bcr 0.05 mg
orb81432 Human fast skeletal Troponin 1 protein Skelatal isoforms of Troponin were suggested to be used as markers of acute and chronic skelatal muscle injuries. In skelatal muscles Troponin is presented by tw 5
orb81853 Respiratory Syncytial Virus Antigen protein Respiratory Syncytial Virus (RSV) Antigen (Strain Long) <10 percent Viral Protein is an infectious disease antigen_toxin. For research use only. 1 ml
orb81121 Human Fibronectin protein Plasma fibronectin level is elevated in severe coronary artery disease. Increased plasma fibronectin levels are related with venous thromboembolism (VTE) particularly in male 200
ILE-RSV01 Infectious Disease ELISA Kits (96 Tests) Respiratory syncytial virus (RSV) IgG 1 kit
ILE-RSV03 Infectious Disease ELISA Kits (96 Tests) Respiratory syncytial virus (RSV) IgM 1 kit
ILE-RSV02 Infectious Disease ELISA Kits (96 Tests) Respiratory syncytial virus (RSV) IgA 1 kit
LC2083 Lung disease spectrum (pulmonary cancer progression) tissue array, 193 cases_208 cores
LC809 Lung disease spectrum (pulmonary cancer progression) tissue array, 78 cases_80 cores
ST-140-04 STREX Mechanical Cell Strain Instrument, unidirectional stretch, multiple chambers Instruments Mechanical Cell Strain Unit and Controller


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur